13F Data
13F filer · CIK 1738053

VHCP Management III, LLC

New York, NY · filing since Q3 2018 · last filing Feb 13, 2020
Reported value
$503.6M
+$341.6M vs prior
Positions
18
New / sold out
9 / 8
Added / reduced
2 / 5
Turnover
16.9%
buys $264.3M · sells $56.2M
Top-10 weight
90.4%

Biggest buys vs Q3 2019

ChangeSecurityShares changeChange %Est. trade value
AddedConstellation Pharmaceuticals+2,449,575+3674.3%+$115.4M
NewRelmada Therapeutics Inc+767,938–+$29.9M
New89Bio Inc+958,765–+$25.2M
NewForty Seven Inc+516,381–+$20.3M
NewIntra-Cellular Therapies Inc+575,000–+$19.7M
NewIveric Bio Inc+1,699,797–+$14.6M
NewAdverum Biotechnologies Inc+946,234–+$10.9M
NewMersana Therapeutics Inc+1,561,389–+$8.9M
NewMyovant Sciences Ltd+455,255–+$7.1M
NewNextcure Inc+119,693–+$6.7M
1 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q3 2019

ChangeSecurityShares changeChange %Est. trade value
Sold outRa Pharmaceuticals-670,350-100.0%$-15.9M
Sold outLa Jolla Pharmaceuticals-1,251,898-100.0%$-11.0M
Sold outBioCryst Pharmaceuticals Inc-2,708,207-100.0%$-7.8M
ReducedProtagonist Therapeutics Inc-991,419-92.5%$-7.0M
ReducedAxsome Therapeutics Inc-63,335-3.9%$-6.5M
Sold outTricida Inc-80,348-100.0%$-2.5M
Sold outKiniksa Pharmaceuticals Ltd-277,137-100.0%$-2.4M
ReducedObseva SA-349,525-30.1%$-1.3M
ReducedBellerophon Therapeutics-2,033,272-84.1%$-709.6K
Sold outRadius Health Inc-23,131-100.0%$-596.0K
3 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q3 2018: $132.3MQ4 2018: $137.6MQ1 2019: $171.5MQ2 2019: $214.2MQ3 2019: $162.0MQ4 2019: $503.6M
Q3 2018Q4 2019

Holdings · Q4 2019

#SecuritySharesValueWeight
1Axsome Therapeutics IncCOM1,547,994$160.0M31.77%
2Constellation PharmaceuticalsCOM2,516,242$118.5M23.54%
3Milestone Pharmaceuticals IncCOM2,066,529$33.1M6.57%
4Relmada Therapeutics IncCOM767,938$29.9M5.95%
589Bio IncCOM958,765$25.2M5.00%
610X Genomics Inc.COM300,000$22.9M4.54%
7Forty Seven IncCOM516,381$20.3M4.04%
8Intra-Cellular Therapies IncCOM575,000$19.7M3.92%
9Iveric Bio IncCOM1,699,797$14.6M2.90%
10Kalvista PharmaceuticalsCOM619,905$11.0M2.19%
8 more rows. Subscribe for $29/month to see every row, download the data and use the API.